[1] Zhang Y, Gao Y, Wang J, et al. Bioenergetic Metabolism Modulatory Peptide Hydrogel for Cardiac Protection and Repair After Myocardial Infarction[J]. Advanced Functional Materials, 2024: 2312772.(IF 19)

[2] Wang Y, Wang W, Gu R, et al. In Situ Vaccination with Mitochondria‐Targeting Immunogenic Death Inducer Elicits CD8+ T Cell‐Dependent Antitumor Immunity to Boost Tumor Immunotherapy[J]. Advanced Science, 2023: 2300286.(IF 15.1)

[3] Cen Y, Chen X, Liu Y, et al. Drug induced mitochondria dysfunction to enhance photodynamic therapy of hypoxic tumors[J]. Journal of Controlled Release, 2023, 358: 654-666.(IF 10.8)

[4] Ren B, Zhang T, Guo Q, et al. Nrf2 Deficiency Attenuates Testosterone Efficiency in Ameliorating Mitochondrial Function of the Substantia Nigra in Aged Male Mice[J]. Oxidative Medicine and Cellular Longevity, 2022, 2022.(IF 7.31)

[5] Sun X, Zeng C, Wang F, et al. Neuromedin S regulates steroidogenesis through maintaining mitochondrial morphology and function via NMUR2 in goat ovarian granulosa cells[J]. International Journal of Molecular Sciences, 2022, 23(21): 13402.(IF 6.208)

[6] Deng K, Liu Z, Su Y, et al. RUNX1T1 modulates myogenic differentiation by regulating the calcium signaling pathway and the alternative splicing of ROCK2[J]. The FASEB Journal, 2023, 37(7): e23044.(IF 4.8)

[7] Zhang T, Chu Y, Wang Y, et al. Testosterone deficiency worsens mitochondrial dysfunction in APP/PS1 mice[J]. Frontiers in Aging Neuroscience, 2024, 16: 1390915. (IF 4.8)

[8] Wang Y, Zou J, Wang Y, et al. Hydralazine inhibits neuroinflammation and oxidative stress in APP/PS1 mice via TLR4/NF-κB and Nrf2 pathways[J]. Neuropharmacology, 2023, 240: 109706.(IF 4.7)